Population-based immunization information systems have been used successfully to assess vaccine effectiveness (VE) in children. The Connecticut Immunization Registry and Tracking system (CIRTS) and the Connecticut Emerging Infections Program (CTEIP) provided the opportunity to evaluate influenza VE among children 6-35 months of age in New Haven County, CT, 2003-2012. A total of 104 case children and 520 date-of-birth- and zipcode-matched controls were studied. The VE in matched analysis of full vaccination compared to no vaccination was 31% (95% CI, \u3c0%-69%; p=0.38). The VE of at least one dose of influenza vaccine compared to no vaccination was 37% (95% CI, \u3c0%-63%; p=0.09). Our study suggests that the overall total VE is unlikely ...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Background and aim of the work: The global burden of disease attributable to seasonal influenza viru...
AbstractBackgroundFactors, such as age, comorbidities, vaccine type, herd immunity, previous influen...
INTRODUCTION: In 2013, the United Kingdom began to roll-out a universal annual influenza vaccination...
OBJECTIVEPrevention of influenza among infants and young children is a public health priority becaus...
SummaryObjectivesWe aimed to estimate the pooled vaccine effectiveness (VE) in children over five wi...
Influenza virus infection is a major cause of morbidity and mortality in at risk populations. Childr...
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters...
IntroductionDepending upon influenza vaccination history, children aged 6 months-8 years need one or...
•Vaccine effectiveness in children visiting an Emergency Department for influenza.•Test negative cas...
Preschool-aged children are at increased risk for severe influenza-related illness and complications...
vaccine for children aged 6 months through 2 years, but no estimates of influenza vaccine coverage o...
One of the groups at increased risk of severe influenza illness is children, particularly young chil...
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Background and aim of the work: The global burden of disease attributable to seasonal influenza viru...
AbstractBackgroundFactors, such as age, comorbidities, vaccine type, herd immunity, previous influen...
INTRODUCTION: In 2013, the United Kingdom began to roll-out a universal annual influenza vaccination...
OBJECTIVEPrevention of influenza among infants and young children is a public health priority becaus...
SummaryObjectivesWe aimed to estimate the pooled vaccine effectiveness (VE) in children over five wi...
Influenza virus infection is a major cause of morbidity and mortality in at risk populations. Childr...
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters...
IntroductionDepending upon influenza vaccination history, children aged 6 months-8 years need one or...
•Vaccine effectiveness in children visiting an Emergency Department for influenza.•Test negative cas...
Preschool-aged children are at increased risk for severe influenza-related illness and complications...
vaccine for children aged 6 months through 2 years, but no estimates of influenza vaccine coverage o...
One of the groups at increased risk of severe influenza illness is children, particularly young chil...
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Background and aim of the work: The global burden of disease attributable to seasonal influenza viru...
AbstractBackgroundFactors, such as age, comorbidities, vaccine type, herd immunity, previous influen...